PaulJ.ShaughnessyMD

Oncology • San Antonio, TX

Hematologic Oncology

Assistant Professor of Medicine, University Tex San Antonio

Join to view full profile

Are you Dr. Shaughnessy?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 83 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
7700 Floyd Curl Dr
10TH floor
San Antonio, TX 78229
Phone+1 210-575-3817

Fax+1 210-575-4113
Is this information wrong?

Summary

Dr. Paul Shaughnessy, MD is an oncologist in San Antonio, Texas. He is currently licensed to practice medicine in Texas and Pennsylvania. He is affiliated with Methodist Hospital and is an Assistant Professor of Medicine at University Tex San Antonio.

Education & Training

San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1994 - 1997
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1991 - 1994
Indiana University School of MedicineClass of 1991

Certifications & Licensure

TX State Medical License 1998 - 2026
PA State Medical License 1993 - 1998
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Top Doctors:SE Texas Castle Connolly, 2013

Clinical Trials

Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
Completed
Phase 3
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
Completed
Phase 3
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Completed
Phase 3
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies Start of enrollment: 2006 Jul 01
Completed
Phase 2
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
Completed
Phase 3
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Selecting a Favorable KIR Donor in Unrelated HCT for AML Start of enrollment: 2011 Jun 01
Completed
Not Applicable
Allogeneic Transplant in HIV Patients (BMT CTN 0903) Start of enrollment: 2011 Sep 01
Completed
Phase 2
P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies Start of enrollment: 2013 Aug 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.
Bhagirathbhai Dholaria, Aleksandar Radujkovic, Noel Estrada-Merly, Tiarlan Sirait, Soyoung Kim, Juan Carlos Hernández-Boluda, Tomasz Czerw, Patrick J Hayden, Ankit Kan...> ;British Journal of Haematology. 2022 Aug 1
4 citations
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
Peter A. Riedell, Mehdi Hamadani, Kwang Woo Ahn, Carlos Litovich, Claudio G. Brunstein, Amanda F. Cashen, Jonathon B. Cohen, Narendranath Epperla, Brian T. Hill, Annie...> ;British Journal of Haematology. 2021 Sep 28
2 citations
Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach.
Justin G. Horowitz, Gerard W Gawrys, Grace C. Lee, Brittney A Ramirez, Carole Elledge, Paul J. Shaughnessy> ;Transplant Infectious Disease. 2021 Jul 13
20 citations
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.
Richard F. Ambinder, Juan Wu, Brent R. Logan, Christine M. Durand, Ryan K. Shields, Uday R. Popat, Richard F. Little, Deborah McMahon, Joshua C. Cyktor, John W. Mellor...> ;Biology of Blood and Marrow Transplantation. 2019 Nov 1
17 citations
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Seema Naik, Marcie L. Riches, Parameswaran Hari, Soyoung Kim, Min Chen, Carlos Bachier, Paul J. Shaughnessy, Joshua A. Hill, Per Ljungman, Minoo Battiwalla, Saurabh Ch...> ;Transplant Infectious Disease. 2019 Oct 1
18 citations
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune...
Mahasweta Gooptu, Haesook T. Kim, Yi Bin Chen, Witold B. Rybka, Andrew S. Artz, Michael Boyer, Laura Johnston, Joseph P. McGuirk, Thomas C. Shea, Madan Jagasia, Paul J...> ;Biology of Blood and Marrow Transplantation. 2018 Nov 1
28 citations
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Shahrukh K. Hashmi, Stephanie J. Lee, Bipin N. Savani, Linda J. Burns, John R. Wingard, Miguel-Angel Perales, Jeanne Palmer, Eric J. Chow, Everett Meyer, David I. Mark...> ;Biology of Blood and Marrow Transplantation. 2018 Jun 1
195 citations
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Pa...
Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold B. Rybka, Andrew S. Artz, David L. Porter, Thomas ...> ;Journal of Clinical Oncology. 2017 Oct 17
109 citations
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
Jeanne Palmer, Jeannine S. McCune, Miguel-Angel Perales, David I. Marks, Joseph S. Bubalo, Mohamad Mohty, John R. Wingard, Angelo Paci, Moustapha Hassan, Christopher B...> ;Biology of Blood and Marrow Transplantation. 2016 Nov 1
19 citations
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.
Mohammed M. Elayan, Justin G. Horowitz, Jose M. Magraner, Paul J. Shaughnessy, Carlos Bachier> ;Biology of Blood and Marrow Transplantation. 2015 Nov 1
5 citations
Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood...
Cesar O. Freytes, Juan J. Toro, Rosa F. Yeh, Edward A. Stadtmauer, Voravit Ratanatharathorn, Gorgun Akpek, Entezam Sahovic, Guido Tricot, Paul J. Shaughnessy, Darrell ...> ;Biology of Blood and Marrow Transplantation. 2014 Dec 1
84 citations
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation
Nina Shah, Natalie S. Callander, Siddhartha Ganguly, Zartash Gul, Mehdi Hamadani, Luciano J. Costa, Salyka Sengsayadeth, Muneer H. Abidi, Parameswaran Hari, Mohamad Mo...> ;Biology of Blood and Marrow Transplantation. 2015 Jul 1
5 citations
Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG
Behyar Zoghi, Paul J. Shaughnessy, Roger M. Lyons, Richard Helmer, Carlos Bachier, C. Frederick LeMaistre> ;Case Reports in Hematology. 2015 Apr 2
146 citations
Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marr...
Hien K. Duong, Bipin N. Savani, Ed Copelan, Steven M. Devine, Luciano J. Costa, John R. Wingard, Paul J. Shaughnessy, Navneet S. Majhail, Miguel-Angel Perales, Corey C...> ;Biology of Blood and Marrow Transplantation. 2014 Sep 1
54 citations
Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guid...
Joseph S. Bubalo, Paul A. Carpenter, Navneet S. Majhail, Miguel-Angel Perales, David I. Marks, Paul J. Shaughnessy, Joseph Pidala, Helen Leather, John R. Wingard, Bipi...> ;Biology of Blood and Marrow Transplantation. 2014 May 1
262 citations
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations
Sergio Giralt, Luciano J. Costa, Jeffrey Schriber, John F. DiPersio, Richard T. Maziarz, John M. McCarty, Paul J. Shaughnessy, Edward L. Snyder, William I. Bensinger, ...> ;Biology of Blood and Marrow Transplantation. 2014 Mar 1
24 citations
Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
Anthony D. Sung, Daniel T. Grima, Lisa M. Bernard, Stephen Brown, George Carrum, Leona Holmberg, Mitchell E. Horwitz, Jane L. Liesveld, Junya Kanda, Brian McClune, Pau...> ;Bone Marrow Transplantation. 2013 Jun 10
22 citations
Pharmacoeconomics of Hematopoietic Stem Cell Mobilization: An Overview of Current Evidence and Gaps in the Literature
Paul J. Shaughnessy, Nelson J. Chao, J. Shapiro, Kent Walters, John M. McCarty, Sunil Abhyankar, Sepideh Shayani, Pieter Helmons, Helen Leather, Amy Pazzalia, Simon Pi...> ;Biology of Blood and Marrow Transplantation. 2013 Sep 1
29 citations
Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.
Paul J. Shaughnessy, Joseph P. Uberti, Steve Devine, Richard T. Maziarz, Julie M. Vose, Ivana N. Micallef, Eric N. Jacobsen, John M. McCarty, Patrick J. Stiff, Andrew ...> ;Bone Marrow Transplantation. 2013 Jun 1
3 citations
G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT.
Ivana N. Micallef, Eric D. Jacobsen, Paul J. Shaughnessy, P J Gandhi, Gary Calandra, F. van Rhee, Joseph P. Uberti> ;Bone Marrow Transplantation. 2013 Feb 1
417 citations
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Paul J. Martin, J. Douglas Rizzo, John R. Wingard, Karen K. Ballen, Peter T. Curtin, Corey Cutler, Mark R. Litzow, Yago Nieto, Bipin N. Savani, Jeffrey Schriber, Paul ...> ;Biology of Blood and Marrow Transplantation. 2012 Aug 1
16 citations
High White Blood Cell Concentration in the Peripheral Blood Stem Cell Product Can Induce Seizures during Infusion of Autologous Peripheral Blood Stem Cells
Carlos Bachier, Josh Potter, Grant W. Potter, Rominna Sugay, Paul J. Shaughnessy, Kawah Chan, Veronica H. Jude, Renee Madden, Charles F. LeMaistre> ;Biology of Blood and Marrow Transplantation. 2012 Jul 1
7 citations
Once daily busulfan cyclophosphamide is well tolerated and effective as a preparative regimen for allogeneic hematopoietic stem cell transplant.
Julia A. LeMaistre, Carlos Bachier, Bradley Smith, C.F. LeMaistre, Paul J. Shaughnessy> ;Journal of Oncology Pharmacy Practice. 2012 Mar 1
78 citations
Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide.
Paul J. Shaughnessy, Miguel Islas-Ohlmayer, Julie Murphy, Maureen Hougham, Jill MacPherson, Kurt Winkler, Matthew A. Silva, Michael Steinberg, Jeffrey Matous, Sheryl S...> ;Biology of Blood and Marrow Transplantation. 2011 May 1
23 citations
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.
Paul J. Martin, Barry E. Storer, Paul A. Carpenter, Daniel R. Couriel, Mary E.D. Flowers, Vikas Gupta, Jack W. Hsu, Madan Jagasia, Carrie L. Kitko, Richard T. Maziarz,...> ;Biology of Blood and Marrow Transplantation. 2011 Jan 1
Join now to see all

Press Mentions

Sarah Cannon Blood Cancer Network Leaders to Present 24 Abstracts at the 2016 BMT Tandem MeetingsFebruary 16th, 2016

Hospital Affiliations

Methodist HospitalSan Antonio, Texas